Enzon Pharmaceuticals Inc

(ENZN)

By |

Profile

Enzon Pharmaceuticals Inc is a pharmaceutical company. Its four licensed products comprise of PegIntron, Sylatron, Macugen, and CIMZIA. PegIntron is used both as a monotherapy and in combination with REBETOL (ribavirin) capsules for the treatment of chronic hepatitis C. Macugen is used for the treatment of neovascular (wet) age-related macular degeneration. Sylatron is used for the treatment of melanoma. CIMZIA is used for the treatment of moderate to severe rheumatoid arthritis and Crohn's disease. CIMZIA is a biologic medicine that counteracts tumor necrosis factor (or TNF), which promotes inflammation of the joints in rheumatoid arthritis.

Contact Information

Website: www.enzon.com
Email: investor@enzon.com
Main Phone: +1 732 980-4500
Address: 20 Commerce Drive
Address 2: Suite 135
State: NJ
City / Town: Cranford
Country: USA
Postal Code: 07016

Issuer Information

Exchange: OTCQX
CEO: Andrew Rackear
Employees: 1
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 0.22 $ 0. (0.00%)
Last Price 0.22 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.22 High 0.23 Low 0.22 Prev Close 0.22
Last Trade Volume 8,616 52 Wk Hi 0.32 52 Wk Low 0.20
Market Cap 9.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 44,214,603.00 EPS (TTM) -0.02 PE Ratio N/A Exchange OTCQX
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Carl C. Icahn 1,000
George W. Hebard 1,000
Mark Ogden 1,000
Last 10 Sell Shares
Robert Lebuhn 1,000
Robert Lebuhn 1,000
Robert Lebuhn 1,000
Robert Lebuhn 1,000
Andrew Rackear 1,000
Richard A. Young 1,000
Andrew Rackear 1,000
Robert Lebuhn 1,000
Robert Lebuhn 1,000
Robert Lebuhn 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 14 14 14 16
Low Target Price Estimate 5 5 5 16
Mean Target Price Estimate 10.5 10.5 8.17 16
Standard Deviation 4.8 4.8 5.06 0
Date of Most Recent Estimate 12/10/08 12/10/08 12/03/08 05/23/11
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 2